Publikationen in Zusammenarbeit mit Forschern von Vall d'Hebron Institut de Recerca (23)

2024

  1. EPITRANS. Quality assessment of the epilepsy transition process

    European Journal of Paediatric Neurology, Vol. 48, pp. 121-128

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. HIV medical care interruption among people living with HIV in Spain, 2004-2020

    AIDS, Vol. 37, Núm. 8, pp. 1277-1284

  4. Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 77, Núm. 9, pp. 1273-1281

2022

  1. Corrigendum: Dynamics of Emergency Cardiovascular Hospital Admissions and In-Hospital Mortality During the COVID-19 Pandemic: Time Series Analysis and Impact of Socioeconomic Factors, (Front. Cardiovasc. Med, (2022), 9, (827212), 10.3389/fcvm.2022.827212)

    Frontiers in Cardiovascular Medicine

  2. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  3. Dynamics of Emergency Cardiovascular Hospital Admissions and In-Hospital Mortality During the COVID-19 Pandemic: Time Series Analysis and Impact of Socioeconomic Factors

    Frontiers in Cardiovascular Medicine, Vol. 9

  4. Interictal brain activity changes in temporal lobe epilepsy: A quantitative electroencephalogram analysis

    Acta Neurologica Scandinavica, Vol. 145, Núm. 2, pp. 239-248

  5. Kosaki overgrowth syndrome due to a novel de novo PDGFRB variant

    Clinical Genetics

  6. Leukodystrophy-Like Phenotype in Anti-MOG Antibody-Associated Disorders

    Neuropediatrics, Vol. 53, Núm. 2, pp. 147-148

  7. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

  8. Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights

    Trials, Vol. 23, Núm. 1

2021

  1. Appropriateness of surgery performed for abdominal aortic aneurysm at tertiary hospitals in Spain

    International Angiology, Vol. 40, Núm. 4, pp. 289-296

  2. Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 72, Núm. 9, pp. 1517-1525

  3. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

    The Lancet, Vol. 398, Núm. 10295, pp. 121-130

  4. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  5. Prevalence of Colorectal Neoplasms Among Patients With Enterococcus faecalis Endocarditis in the GAMES Cohort (2008–2017)

    Mayo Clinic Proceedings, Vol. 96, Núm. 1, pp. 132-146

2020

  1. An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 3, pp. 730-737

2019

  1. Variation in the choice of elective surgical procedure for abdominal aortic aneurysm in spain

    Vascular Health and Risk Management, Vol. 15, pp. 69-79